Shares of Reckitt Benckiser Group plc (LON:RKT – Get Free Report) shot up 2.6% on Thursday . The stock traded as high as GBX 6,300 and last traded at GBX 6,289. 4,216,770 shares traded hands during trading, a decline of 49% from the average session volume of 8,225,884 shares. The stock had previously closed at GBX 6,127.
Analysts Set New Price Targets
RKT has been the subject of a number of research analyst reports. Royal Bank Of Canada downgraded shares of Reckitt Benckiser Group to a “sector perform” rating and cut their price target for the company from GBX 6,400 to GBX 6,200 in a report on Wednesday, January 14th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Reckitt Benckiser Group from GBX 5,600 to GBX 5,700 and gave the stock a “buy” rating in a report on Friday, October 24th. JPMorgan Chase & Co. lifted their price target on shares of Reckitt Benckiser Group from GBX 5,500 to GBX 6,100 and gave the stock a “neutral” rating in a research report on Wednesday, November 26th. Jefferies Financial Group increased their price objective on Reckitt Benckiser Group from GBX 5,500 to GBX 5,700 and gave the company a “hold” rating in a research report on Wednesday, January 7th. Finally, UBS Group restated a “buy” rating and issued a GBX 7,700 target price on shares of Reckitt Benckiser Group in a report on Friday, October 17th. Three research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, Reckitt Benckiser Group presently has a consensus rating of “Hold” and a consensus target price of GBX 6,279.29.
Check Out Our Latest Research Report on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Up 2.2%
Reckitt Benckiser Group Company Profile
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Featured Stories
- Five stocks we like better than Reckitt Benckiser Group
- Your Bank Account Is No Longer Safe
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- When to buy gold (mathematically)
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
